RRC ID 38515
著者 Kodama T, Togawa T, Tsukimura T, Kawashima I, Matsuoka K, Kitakaze K, Tsuji D, Itoh K, Ishida Y, Suzuki M, Suzuki T, Sakuraba H.
タイトル Lyso-GM2 ganglioside: a possible biomarker of Tay-Sachs disease and Sandhoff disease.
ジャーナル PLoS One
Abstract To find a new biomarker of Tay-Sachs disease and Sandhoff disease. The lyso-GM2 ganglioside (lyso-GM2) levels in the brain and plasma in Sandhoff mice were measured by means of high performance liquid chromatography and the effect of a modified hexosaminidase (Hex) B exhibiting Hex A-like activity was examined. Then, the lyso-GM2 concentrations in human plasma samples were determined. The lyso-GM2 levels in the brain and plasma in Sandhoff mice were apparently increased compared with those in wild-type mice, and they decreased on intracerebroventricular administration of the modified Hex B. The lyso-GM2 levels in plasma of patients with Tay-Sachs disease and Sandhoff disease were increased, and the increase in lyso-GM2 was associated with a decrease in Hex A activity. Lyso-GM2 is expected to be a potential biomarker of Tay-Sachs disease and Sandhoff disease.
巻・号 6(12)
ページ e29074
公開日 2011-1-1
DOI 10.1371/journal.pone.0029074
PII PONE-D-11-20535
PMID 22205997
PMC PMC3243693
MeSH Adult Animals Biomarkers / blood Biomarkers / metabolism Brain / metabolism G(M2) Activator Protein / deficiency G(M2) Ganglioside / analogs & derivatives* G(M2) Ganglioside / blood G(M2) Ganglioside / metabolism Hexosaminidases / blood Humans Infant Mice Sandhoff Disease / blood Sandhoff Disease / enzymology Sandhoff Disease / metabolism* Tay-Sachs Disease / blood Tay-Sachs Disease / enzymology Tay-Sachs Disease / metabolism*
IF 2.74
引用数 15
WOS 分野 BIOCHEMISTRY & MOLECULAR BIOLOGY
リソース情報
ヒト・動物細胞 CHO